Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.
28 August 2017 (08:30 - 12:30)
Organised by:
Abstract
About the speaker

IRCCS San Raffaele Scientific Institute, Milan (Italy)
53 More presentations in this session
Access the full session
The Event
ESC Congress 2017
28 August 2017
08:30 CET
